APAlessandro Pirosa

Alessandro Pirosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alessandro Pirosa has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An in vitro chondro-osteo-vascular triphasic model of the osteochondral complex

    by Alessandro Pirosa, Riccardo Gottardi, Peter G. Alexander, Dario Puppi, Federica Chiellini, Rocky S. Tuan


  • Open Access

    Engineering in-vitro stem cell-based vascularized bone models for drug screening and predictive toxicology

    by Alessandro Pirosa, Riccardo Gottardi, Peter G. Alexander, Rocky S. Tuan

    The production of veritable in-vitro models of bone tissue is essential to understand the biology of bone and its surrounding environment, to analyze the pathogenesis of bone diseases (e.g., osteoporosis, osteoarthritis, osteomyelitis, etc.), to develop effective therapeutic drug screening, and to test potential therapeutic strategies. Dysregulated interactions between vasculature and bone cells are often related to the aforementioned pathologies, underscoring the need for a bone model that contains engineered vasculature. Due to ethical restraints and limited prediction power of animal models, human stem cell-based tissue engineering has gained increasing relevance as a candidate approach to overcome the limitations of animals and to serve as preclinical models for drug testing. Since bone is a highly vascularized tissue, the concomitant development of vasculature and mineralized matrix requires a synergistic interaction between osteogenic and endothelial precursors. A number of experimental approaches have been used to achieve this goal, such as the combination of angiogenic factors and three-dimensional scaffolds, prevascularization strategies, and coculture systems. In this review, we present an overview of the current models and approaches to generate in-vitro stem cell-based vascularized bone, with emphasis on the main challenges of vasculature engineering. These challenges are related to the choice of biomaterials, scaffold fabrication techniques, and cells, as well as the type of culturing conditions required, and specifically the application of dynamic culture systems using bioreactors.


  • Design, fabrication and characterization of tailored poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyexanoate] scaffolds by computer-aided wet-spinning

    by Dario Puppi, Alessandro Pirosa, Andrea Morelli, Federica Chiellini

    Purpose: The purpose of this paper is to describe the fabrication and characterization of poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyexanoate] (PHBHHx) tissue engineering scaffolds with anatomical shape and customized porous structure. Design/methodology/approach: Scaffolds with external shape and size modeled on a critical size segment of a rabbit’s radius model and an internal macrochanneled porous structure were designed and fabricated by means of a computer-aided wet-spinning (CAWS) technique. Morphological, thermal and mechanical characterization were carried out to assess the effect of the fabrication process on material properties and the potential of the PHBHHx scaffolds in comparison with anatomical star poly(e-caprolactone) (*PCL) scaffolds previously validated in vivo. Findings: The CAWS technique is well suited for the layered manufacturing of anatomical PHBHHx scaffolds with a tailored porous architecture characterized by a longitudinal macrochannel. Morphological analysis showed that the scaffolds were composed by overlapping layers of microfibers with a spongy morphology, forming a 3D interconnected network of pores. Physical-chemical characterization indicated that the used technique did not affect the molecular structure of the processed polymer. Analysis of the compressive and tensile mechanical properties of the scaffolds highlighted the anisotropic behavior of the porous structure and the effect of the macrochannel in enhancing scaffold compressive stiffness. In comparison to the *PCL scaffolds, PHBHHx scaffolds showed higher compressive stiffness and tensile deformability. Originality/value: This study shows the possibility of using renewable microbial polyester for the fabrication of scaffolds with anatomical shape and internal architecture tailored for in vivo bone regeneration studies.


  • Design and fabrication of novel polymeric biodegradable stents for small caliber blood vessels by computer-aided wet-spinning

    by D Puppi, A Pirosa, G Lupi, P A Erba, G Giachi, F Chiellini

    Biodegradable stents have emerged as one of the most promising approaches in obstructive cardiovascular disease treatment due to their potential in providing mechanical support while it is needed and then leaving behind only the healed natural vessel. The aim of this study was to develop polymeric biodegradable stents for application in small caliber blood vessels. Poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate] (PHBHHx), a renewable microbial aliphatic polyester, and poly( ε -caprolactone), a synthetic polyester approved by the US Food and Drug Administration for different biomedical applications, were investigated as suitable polymers for stent development. A novel manufacturing approach based on computer-aided wet-spinning of a polymeric solution was developed to fabricate polymeric stents. By tuning the fabrication parameters, it was possible to develop stents with different morphological characteristics (e.g. pore size and wall thickness). Thermal analysis results suggested that material processing did not cause changes in the molecular structure of the polymers. PHBHHx stents demonstrated great radial elasticity while PCL stents showed higher axial and radial mechanical strength. The developed stents resulted able to sustain proliferation of human umbilical vein endothelial cells within two weeks of in vitro culture and they showed excellent results in terms of thromboresistivity when in contact with human blood.


  • Integrated three‐dimensional fiber/hydrogel biphasic scaffolds for periodontal bone tissue engineering

    by Dario Puppi, Chiara Migone, Lucia Grassi, Alessandro Pirosa, Giuseppantonio Maisetta, Giovanna Batoni, Federica Chiellini

    Combining a tissue engineering scaffold made of a load‐bearing polymer with a hydrogel represents a powerful approach to enhancing the functionalities of the resulting biphasic construct, such as its mechanical properties or ability to support cellular colonization. This research activity was aimed at the development of biphasic scaffolds through the combination of an additively manufactured poly(ϵ‐caprolactone) (PCL) fiber construct and a chitosan/poly(γ‐glutamic acid) polyelectrolyte complex hydrogel. By investigating a set of layered structures made of PCL or PCL/hydroxyapatite composite, biphasic scaffold prototypes with good integration of the two phases at the macroscale and microscale were developed. The biphasic constructs were able to absorb cell culture medium up to 10‐fold of their weight, and the combination of the two phases had a significant influence on compressive mechanical properties compared with hydrogel or PCL scaffold alone. In addition, due to the presence of chitosan in the hydrogel phase, biphasic scaffolds exerted a broad‐spectrum antibacterial activity. The developed biphasic systems appear well suited for application in periodontal bone regenerative approaches in which a biodegradable porous structure providing mechanical stability and a hydrogel phase functioning as absorbing depot of endogenous proteins are simultaneously required. © 2016 Society of Chemical Industry


  • Levofloxacin-loaded star poly(ε-caprolactone) scaffolds by additive manufacturing

    by Dario Puppi, Anna Maria Piras, Alessandro Pirosa, Stefania Sandreschi, Federica Chiellini

    The employment of a tissue engineering scaffold able to release an antimicrobial agent with a controlled kinetics represents an effective tool for the treatment of infected tissue defects as well as for the prevention of scaffolds implantation-related infectious complications. This research activity was aimed at the development of additively manufactured star poly(ε-caprolactone) (*PCL) scaffolds loaded with levofloxacin, investigated as antimicrobial fluoroquinolone model. For this purpose a computer-aided wet-spinning technique allowing functionalizing the scaffold during the fabrication process was explored. Scaffolds with customized composition, microstructure and anatomical external shape were developed by optimizing the processing parameters. Morphological, thermal and mechanical characterization showed that drug loading did not compromise the fabrication process and the final performance of the scaffolds. The developed *PCL scaffolds showed a sustained in vitro release of the loaded antibiotic for 5 weeks. The proposed computer-aided wet-spinning technique appears well suited for the fabrication of anatomical scaffolds endowed with levofloxacin-releasing properties to be tested in vivo for the regeneration of long bone critical size defects in a rabbit model.


  • Open Access

    In VitroBehavior of Human Adipose Tissue-Derived Stem Cells on Poly(ε-caprolactone) Film for Bone Tissue Engineering Applications

    by Cecilia Romagnoli, Roberto Zonefrati, Gianna Galli, Dario Puppi, Alessandro Pirosa, Federica Chiellini, Francesco Saverio Martelli, Annalisa Tanini, Maria Luisa Brandi

    Bone tissue engineering is an emerging field, representing one of the most exciting challenges for scientists and clinicians. The possibility of combining mesenchymal stem cells and scaffolds to create engineered tissues has brought attention to a large variety of biomaterials in combination with osteoprogenitor cells able to promote and regenerate bone tissue. Human adipose tissue is officially recognized as an easily accessible source of mesenchymal stem cells (AMSCs), a significant factor for use in tissue regenerative medicine. In this study, we analyze the behavior of a clonal finite cell line derived from human adipose tissue seeded on poly(ε-caprolactone) (PCL) film, prepared by solvent casting. PCL polymer is chosen for its good biocompatibility, biodegradability, and mechanical properties. We observe that AMSCs are able to adhere to the biomaterial and remain viable for the entire experimental period. Moreover, we show that the proliferation process and osteogenic activity of AMSCs are maintained on the biofilm, demonstrating that the selected biomaterial ensures cell colonization and the development of an extracellular mineralized matrix. The results of this study highlight that AMSCs and PCL film can be used as a suitable model to support regeneration of new bone for future tissue engineering strategies.


  • Open Access

    Tailored star poly (ε-caprolactone) wet-spun scaffolds for in vivo regeneration of long bone critical size defects

    by Francesca Dini, Giovanni Barsotti, Dario Puppi, Alessandra Coli, Angela Briganti, Elisabetta Giannessi, Vincenzo Miragliotta, Carlos Mota, Alessandro Pirosa, Maria R Stornelli, et al.

    One of the most challenging requirements of a successful bone tissue engineering approach is the development of scaffolds specifically tailored to individual tissue defects. Besides materials chemistry, well-defined scaffold’s structural features at the micro- and macro-levels are needed for optimal bone in-growth. In this study, polymeric fibrous scaffolds with a controlled internal network of pores and modelled on the anatomical shape and dimensions of a critical size bone defect in a rabbit’s radius model were developed by employing a computer-aided wet-spinning technique. The tailored scaffolds made of star poly(ε-caprolactone) or star poly(ε-caprolactone)–hydroxyapatite composite material were implanted into 20-mm segmental defects created in radial diaphysis of New Zealand white rabbits. Bone regeneration and tissue response were assessed by X-rays and histological analysis at 4, 8 and 12 weeks after surgery. No signs of macroscopic and microscopic inflammatory reactions were detected, and the developed scaffolds showed a good ability to support and promote the bone regeneration process. However, no significant differences in osteoconductivity were observed between star poly(ε-caprolactone) and star poly(ε-caprolactone)–hydroxyapatite scaffolds. Long-term study on implanted star poly(ε-caprolactone) scaffolds confirmed the presence of signs of bone regeneration and remodelling, particularly evident at 24 weeks.